Mannkind (MNKD) EBIT Margin Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -170.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3,724.00 |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | -3,030.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,030.00 |
| Dec 31, 2025 | -4,138.00 |
| Sep 30, 2025 | 480.00 |
| Jun 30, 2025 | -1,602.00 |
| Mar 31, 2025 | 322.00 |
| Dec 31, 2024 | 2,107.00 |
| Sep 30, 2024 | 826.00 |
| Jun 30, 2024 | 1,941.00 |
| Mar 31, 2024 | 4,000.00 |
| Dec 31, 2023 | 4,891.00 |
| Sep 30, 2023 | 3,922.00 |
| Jun 30, 2023 | 682,154.00 |
| Mar 31, 2023 | 16,249.00 |
| Dec 31, 2022 | 15,604.00 |
| Sep 30, 2022 | 39.00 |
| Jun 30, 2022 | -677,387.00 |
| Mar 31, 2022 | -14,174.00 |
| Dec 31, 2021 | -6,276.00 |
| Sep 30, 2021 | 2,980.00 |
| Jun 30, 2021 | 391,337.00 |
| Mar 31, 2021 | 836.00 |
| Dec 31, 2020 | -5,778.00 |
| Sep 30, 2020 | 119,467.00 |
| Jun 30, 2020 | 151,850.00 |
| Mar 31, 2020 | 3,359.00 |
| Dec 31, 2019 | -2,276.00 |
| Sep 30, 2019 | -77,209.00 |
| Jun 30, 2019 | -494,846.00 |
| Mar 31, 2019 | 69,568.00 |
| Dec 31, 2018 | 58,836.00 |
| Sep 30, 2018 | 89,724.00 |
| Jun 30, 2018 | 93,206.00 |
| Mar 31, 2018 | -12,169.00 |
| Dec 31, 2017 | -54,118.00 |
| Sep 30, 2017 | -145,212.00 |